SITC Archive Library

Back to Library

2016 New Cancer Immunotherapy Agents in Development 

02-13-2017 16:32

The Society for Immunotherapy of Cancer (SITC) hosted the "New Cancer Immunotherapy Agents in Development" program at the 2016 Annual Meeting & Associated Programs on November 9, 2016. Available here are the presentation slides and video.

Organizers

  • Adrian Bot, MD, PhD – Kite Pharma, Inc.
  • Daniel S. Chen, MD, PhD – Genentech
  • Roger D. Dansey, MD – Merck & Co., Inc.
  • Ramy Ibrahim, MD – The Parker Institute for Cancer Immunotherapy (formerly AstraZeneca)
  • Salil Patel, PhD – Bristol-Myers Squibb

Program Summary

Organized in collaboration with the SITC Annual Program Committee and SITC Industry Committee, this program at the SITC 2016 Annual Meeting & Associated Programs on November 9, 2016 in National Harbor, MD consisted of rapid-fire presentations on cutting-edge new cancer immunotherapy agents in development and an extended panel session discussing strategic considerations of combinations and biomarkers in current and future agents.

Target Audience
The intended audience for this program included, but was not limited to basic, translational and clinical researchers; postdoctoral fellows; clinicians; and payers involved in cancer research from such affiliations as academia, industry and regulatory agencies.

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.

#Researcher#AnnualMeeting#PresentationSlides#2016#Clinician
#Oncologist#Industry#SITC#RegisteredNurse#ClinicalTrials#Biomarkers
#ColorectalCancer#HeadandNeckCancers#Melanoma#RenalCellCarcinoma
#NonSmallCellLungCancer#Video#Atezolizumab#Avelumab#Ipilimumab
#Nivolumab#CombinationTherapy#Cytokines#AdverseEvents#Toxicities

Statistics
1 Favorited
125 Views
17 Files
0 Shares
952 Downloads

 Video
​
Attachment(s)
Download All
pdf file
2503 in Combination with Ipilimumab or Antibody to PD-1 o...   1.95 MB   1 version
Uploaded - 02-13-2017
Meeting: 2016 New Cancer Immunotherapy Agents in Development; Session: New Agents in Development; Presenter: Elizabeth Evans, PhD – Vaccinex, Inc; Date: November 9, 2016
 
Download
pdf file
An Investigational Intratumoral Toll-Like Receptor 9 Ago...   2.81 MB   1 version
Uploaded - 02-13-2017
Meeting: 2016 New Cancer Immunotherapy Agents in Development; Session: New Agents in Development; Presenter: Mark Cornfeld, MD, MPH – Idera Pharmaceuticals; Date: November 9, 2016
 
Download
mp4 file
An Investigational Intratumoral Toll-Like Receptor 9 Ago...   59.26 MB   1 version
Uploaded - 02-15-2017
Meeting: 2016 New Cancer Immunotherapy Agents in Development; Session: New Agents in Development; Presenter: Mark Cornfeld, MD, MPH – Idera Pharmaceuticals; Date: November 9, 2016
 
Download
pdf file
"Cobimetinib in Combination with Atezolizumab" - Presenta...   2.85 MB   1 version
Uploaded - 02-13-2017
Meeting: 2016 New Cancer Immunotherapy Agents in Development; Session: New Agents in Development; Presenter: Edward Cha – Genentech; Date: November 9, 2016
 
Download
mp4 file
"Cobimetinib in Combination with Atezolizumab" - Video   63.50 MB   1 version
Uploaded - 02-15-2017
Meeting: 2016 New Cancer Immunotherapy Agents in Development; Session: New Agents in Development; Presenter: Edward Cha – Genentech; Date: November 9, 2016
 
Download
pdf file
"Safety of the Natural Killer (NK) Cell-Targeted Anti-KIR...   448 KB   1 version
Uploaded - 02-13-2017
Meeting: 2016 New Cancer Immunotherapy Agents in Development; Session: New Agents in Development; Presenter: F. Stephen Hodi, MD – Dana-Farber Cancer Institute; Date: November 9, 2016
 
Download
mp4 file
"Safety of the Natural Killer (NK) Cell-Targeted Anti-KIR...   53.98 MB   1 version
Uploaded - 02-15-2017
Meeting: 2016 New Cancer Immunotherapy Agents in Development; Session: New Agents in Development; Presenter: F. Stephen Hodi, MD – Dana-Farber Cancer Institute; Date: November 9, 2016
 
Download
pdf file
"A CD122-Biased Agonist Increases CD8+T Cells and Natural...   2.59 MB   1 version
Uploaded - 02-13-2017
Meeting: 2016 New Cancer Immunotherapy Agents in Development; Session: New Agents in Development; Presenter: Adi Diab, MD – MD Anderson Cancer Center; Date: November 9, 2016
 
Download
mp4 file
"A CD122-Biased Agonist Increases CD8+T Cells and Natural...   69.77 MB   1 version
Uploaded - 02-15-2017
Meeting: 2016 New Cancer Immunotherapy Agents in Development; Session: New Agents in Development; Presenter: Adi Diab, MD – MD Anderson Cancer Center; Date: November 9, 2016
 
Download
pdf file
HER2 Bispecific" - Presentation Slides   3.16 MB   1 version
Uploaded - 02-13-2017
Meeting: 2016 New Cancer Immunotherapy Agents in Development; Session: Pre-Clinical New Agents in Development; Presenter: Shane A. Olwill, PhD – Pieris Pharmaceuticals, Inc.; Date: November 9, 2016
 
Download
mp4 file
HER2 Bispecific" - Video   79.61 MB   1 version
Uploaded - 02-15-2017
Meeting: 2016 New Cancer Immunotherapy Agents in Development; Session: Pre-Clinical New Agents in Development; Presenter: Shane A. Olwill, PhD – Pieris Pharmaceuticals, Inc.; Date: November 9, 2016
 
Download
pdf file
A Small Molecule Orally Available Checkpoint Inhibitor" ...   622 KB   1 version
Uploaded - 02-13-2017
Meeting: 2016 New Cancer Immunotherapy Agents in Development; Session: Pre-Clinical New Agents in Development; Presenter: David Tuck, MD – Curis; Date: November 9, 2016
 
Download
mp4 file
A Small Molecule Orally Available Checkpoint Inhibitor" ...   87.30 MB   1 version
Uploaded - 02-15-2017
Meeting: 2016 New Cancer Immunotherapy Agents in Development; Session: Pre-Clinical New Agents in Development; Presenter: David Tuck, MD – Curis; Date: November 9, 2016
 
Download
pdf file
"LAG-3Ig (IMP321) in Combination with Anti-PD-1 Therapy" ...   379 KB   1 version
Uploaded - 02-13-2017
Meeting: 2016 New Cancer Immunotherapy Agents in Development; Session: Pre-Clinical New Agents in Development; Presenter: Frederic Triebel, MD, PhD – Prima Biomed Ltd; Date: November 9, 2016
 
Download
mp4 file
"LAG-3Ig (IMP321) in Combination with Anti-PD-1 Therapy" ...   48.39 MB   1 version
Uploaded - 02-15-2017
Meeting: 2016 New Cancer Immunotherapy Agents in Development; Session: Pre-Clinical New Agents in Development; Presenter: Frederic Triebel, MD, PhD – Prima Biomed Ltd; Date: November 9, 2016
 
Download
pdf file
"Combinations & Biomarkers" - Presentation Slides   2.41 MB   1 version
Uploaded - 02-13-2017
Meeting: 2016 New Cancer Immunotherapy Agents in Development; Session: Strategic Considerations of Combinations and Biomarkers in New Agent Development; Presenter: Charles G. Drake, MD, PhD – Columbia University Herbert Irving Comprehensive Cancer Center; Date: November 9, 2016
 
Download
mp4 file
"Combinations & Biomarkers" - Video   327.13 MB   1 version
Uploaded - 02-15-2017
Meeting: 2016 New Cancer Immunotherapy Agents in Development; Session: Strategic Considerations of Combinations and Biomarkers in New Agent Development; Presenter: Charles G. Drake, MD, PhD – Columbia University Herbert Irving Comprehensive Cancer Center; Date: November 9, 2016
 
Download